In glioma, a HMGA2/GCN5 protein complex promoted histone acetylation in nucleosomes at AT-rich DNA sites, to cause gene activation of matrix metalloproteinase 2 (MMP2), a mediator of invasiveness in glioma, and conferring a poor prognosis [80]. The gene discussed is HMGA2; the disease is central nervous system cancer.